Historical record - last NADAC effective date: 8/21/2024
Product Information
MORPHINE SULFATE ER 100 MG CAP is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $6.6922 per EA under NDC 00832023300. Its NADAC has been published 346 times since Feb 5, 2014.
FDA first approved this application on Jun 3, 2013.
Strength
100 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00832023300
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/21/2024
Active Ingredients
MORPHINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA202104FDA Approved
6/3/2013
On Market Since
6/30/2013
Pharmacological Classes
Price Statistics
The NADAC for MORPHINE SULFATE ER 100 MG CAP has been published 346 times since Feb 5, 2014, and over the history we have for it it has declined 49.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.6922 per EA |
|---|---|
| All-time high | $14.1623 (Oct 14, 2015) |
| All-time low | $6.0842 (Jul 17, 2024) |
| Median price | $11.4575 |
| Average price | $10.6129 |
| Largest weekly change | -50.9% (Apr 17, 2024) |
| Weeks tracked | 346 |
| Tracking since | Feb 5, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-47.1%
5Y
-47.1%
All
-49.0%
Last surveyed Aug 13, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Morphine Sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MORPHINE SULFATE ER 100 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for MORPHINE SULFATE ER 100 MG CAP, manufactured by Upsher-Smith Laboratories LLC, is $6.6922 per EA (NDC 00832023300), effective Aug 13, 2025.
How has the price of MORPHINE SULFATE ER 100 MG CAP changed over time?
Over the history we have for it, the NADAC for MORPHINE SULFATE ER 100 MG CAP has declined 49.0%. It has been tracked across 346 weekly CMS publications since Feb 5, 2014.
What are the highest and lowest recorded NADAC prices for MORPHINE SULFATE ER 100 MG CAP?
Since Feb 5, 2014, the NADAC for MORPHINE SULFATE ER 100 MG CAP has ranged from a low of $6.0842 (Jul 17, 2024) to a high of $14.1623 (Oct 14, 2015), with a median of $11.4575 per EA.
Are there cheaper alternatives to MORPHINE SULFATE ER 100 MG CAP?
No other NADAC-published product currently shares the active ingredient and strength of MORPHINE SULFATE ER 100 MG CAP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MORPHINE SULFATE ER 100 MG CAP?
MORPHINE SULFATE ER 100 MG CAP (NDC 00832023300) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.